Overview

(for NHS decision-makers)

SemaPen provides a digital-first, fully remote pathway for weight management. Patients access a modern app, connected smart scales and structured education to drive behaviour change. NHS GP referrals are accepted via the NHS secure email route; patient accounts are created the same day and onboarding begins immediately.

What patients see

The app experience

Simple, supportive and built for adherence. Patients use the SemaPen app to complete onboarding, track progress and access structured learning and community support — all without clinic visits.

Patient dashboard (at-a-glance progress)

Weight trend (auto-synced from smart scales)

Academy lesson tiles

“Badge earned” confirmation

Food logger / tracker

Community forum (moderated)

ID-check confirmation

Programme option 1:

SemaHealth (non-drug)

Intensive meal replacement + behaviour change, fully remote.


SemaHealth combines total diet replacement (Altralife) with structured food reintroduction, delivered alongside:


  • The SemaPen Academy (nutrition, mindfulness, “fitness without the gym”)
  • A food logger/tracker
  • A moderated patient forum
  • Light gamification (digital badges)
  • Cloud-linked smart scales for effortless weight updates


Typical outcome: patients can expect 12–15% average weight loss over 12 months¹.


Who it suits: patients referred by GPs where medication is not appropriate or not preferred, or where a non-drug pathway is clinically indicated.

Programme option 2:

SemaPen (drug-based)

GLP-1 digital programme for eligible patients.

 

We support Wegovy (semaglutide) and Mounjaro (tirzepatide) within a digital model designed to maximise adherence and safety.


NHS referral cohort includes: full app access (as above) plus connected smart scales — i.e. a Silver-equivalent feature set. (No vitamins or psychologist sessions are included for this cohort.).

Referral pathway for GPs (no IT lift)

1. Refer via NHS secure email route (GP-to-service).

2. SemaPen parses the referral and creates the patient account the same day.

3. The patient completes the standard onboarding flow, including a short video appointment for ID verification.

4. The patient proceeds directly into the appropriate programme. (NHS-referred patients do not see payment screens — funding is handled on the NHS side.)

Patient communications

Patients contact their support team via the in-app support box (asynchronous messaging). Appointments, where needed, are scheduled via Calendly.

Education: The SemaPen Academy

Structured, short-form lessons across:

Recipes & diet advice

Mindfulness for weight loss

Fitness without the gym

Content is reviewed by the SemaPen clinical team (including nutritionists). Patients earn digital badges as they complete modules, reinforcing habit formation.

Sword Health Move

(for NHS referrals)

NHS-referred patients also receive access to Sword Health’s Move: weekly, tailored movement plans with specialist oversight and optional wearable integration — targeting inactivity and MSK risk while supporting overall cardiometabolic health.



Governance & infrastructure (plain English)

Structured, short-form lessons across:

Clinical oversight: led by Professor David Kerrigan

Platform: Laravel backend; UK-based hosting; Cloudflare; SSL/TLS; role-based access control and logging

Data: accounts initiated from GP referral; identity verified during onboarding; patient progress and co-morbidity self-reports stored securely to guide care

Registration

SemaPen Pharmacy — GPhC 9012927.


Programme delivery includes pharmacy governance aligned to UK standards.

Why consider SemaPen

Digital & remote


Minimal service burden; rapid start for patients

Meaningful results


Non-drug pathway with 12–15% average weight loss¹; drug-based option for eligible patients

Whole-person support

Nutrition, movement (Sword Health Move), education, forum and light gamification

Low operational friction

Email referral; same-day account creation; consistent onboarding and identity checks

Based on SemaHealth programme outcomes for intensive meal replacement with structured reintroduction over a 12-month pathway.